AMARIN CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7009 USD | +0.39% |
|
-1.42% | -19.44% |
Chart calendar Amarin Corporation plc
75fc475319ce.a_8NOkkYYm5fcd52iode2uZBtNNdLh7TbYFxgNMh50E.W5RPCAh7BDgLJJY0_8Jptrkp5eI_GkSZIdkV6aVWgzkCmD9leX4GWxIr6g~8c0357c2f7b7791dcc6790e483a09640
Upcoming events on Amarin Corporation plc
Past events on Amarin Corporation plc
| 20/05/2024 21:30 | H.C. Wainwright BioConnect Investor Conference |
| 01/05/2024 13:00 | Q1 2024 Earnings Call |
| 01/05/2024 12:00 | Q1 2024 Earnings Release |
| 08/04/2024 17:45 | American College of Cardiology Scientific Meeting |
| 07/04/2024 18:15 | American College of Cardiology Scientific Meeting |
| 07/04/2024 14:30 | American College of Cardiology Scientific Meeting - Poster No: 06 |
| 06/04/2024 20:30 | American College of Cardiology Scientific Meeting - Poster No: 06 |
| 06/04/2024 17:15 | American College of Cardiology Scientific Meeting - Poster No: 08 |
| 29/02/2024 13:00 | Q4 2023 Earnings Call |
| 29/02/2024 12:00 | Q4 2023 Earnings Release |
| 10/01/2024 21:30 | JPMorgan Healthcare Conference |
| 12/11/2023 16:30 | American Heart Association Scientific Meeting - Om P Ganda |
| 12/11/2023 14:00 | American Heart Association Scientific Meeting - Michael Miller |
| 11/11/2023 16:30 | American Heart Association Scientific Meeting - Peter Libby |
| 11/11/2023 16:30 | American Heart Association Scientific Meeting - Preston Mason |
| 01/11/2023 12:00 | Q3 2023 Earnings Call |
| 01/11/2023 11:00 | Q3 2023 Earnings Release |
| 26/09/2023 14:55 | Cantor Global Healthcare Conference |
| 27/08/2023 15:14 | European Society of Cardiology Congress |
| 27/08/2023 10:05 | European Society of Cardiology Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 430 424 1.32% | 614 610 0.62% | 583 581 0.44% | 369 368 0.3% | 307 303 1.19% | 202 |
|
EBITDA Million USD | Released Forecast Spread | -24,1 -35,5 32.09% | -19,1 -19,5 2.15% | 24,8 -1,48 1770.48% | -47,5 -95,3 50.15% | -67,4 -76,3 11.63% | -50,5 |
|
EBIT Million USD | Released Forecast Spread | -24,3 -38,5 36.91% | -19,7 -29,9 34.26% | 24,2 -12,1 300.13% | -74,3 -88,2 15.82% | -67,6 -59,8 -13.07% | -56,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,5 -40,0 43.77% | -17,3 -29,0 40.58% | 11,3 -13,3 185.08% | -104 -99,0 -4.82% | -53,7 -64,5 16.74% | -51,8 |
|
Net income Million USD | Released Forecast Spread | -22,6 -38,1 40.52% | -18,0 -27,5 34.63% | 7,73 -14,0 155.11% | -106 -105 -0.46% | -59,1 -66,6 11.23% | -70,5 |
|
EPS USD | Released Forecast Spread | -0,07 -0,11 34.3% | -0,05 -0,08 33.56% | 0,02 -0,03 157.6% | -0,26 -0,26 0.61% | -0,15 -0,16 7.02% | -0,18 |
| Announcement Date | 25/02/20 | 25/02/21 | 01/03/22 | 01/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 94,6 128 -26.19% | 94,4 88,2 7.06% | 89,9 88,2 1.86% | 90,2 89,2 1.19% | 86,0 81,2 5.85% | 80,2 74,5 7.58% | 66,1 58,5 12.88% | 74,7 71,1 5.08% | 56,5 57,0 -0.92% | 48,6 | 46,7 | 50,3 | 48,2 |
|
EBITDA Million USD | Released Forecast Spread | -27,5 -10,0 -175.27% | -37,5 -34,0 -10.22% | -5,01 -27,0 81.46% | -3,03 -6,00 49.52% | -17,3 -15,0 -15.19% | -4,80 -14,0 65.69% | |||||||
|
EBIT Million USD | Released Forecast Spread | -28,3 -6,72 -320.98% | -37,6 -26,2 -43.84% | 1,43 -24,1 105.92% | -9,77 -3,66 -166.65% | -17,3 -11,3 -52.87% | -24,0 -18,4 -30.46% | -21,5 -22,0 2.56% | -4,84 -13,7 64.82% | -13,6 -11,8 -15.28% | -13,3 | -15,0 | -14,7 | -5,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,4 -5,94 -377.41% | -64,8 -26,3 -146.03% | -3,88 -23,3 83.32% | -6,77 -2,00 -238.65% | -14,5 -13,9 -4.29% | -17,9 -12,4 -45.06% | -18,8 -22,4 15.84% | -2,45 -14,0 82.44% | -8,66 -8,64 -0.2% | -15,6 | -15,2 | -15,4 | |
|
Net income Million USD | Released Forecast Spread | -31,6 -5,83 -441.12% | -70,0 -24,7 -183.5% | -5,14 -21,0 75.54% | 0,86 -1,87 145.86% | -16,5 -14,5 -13.71% | -17,6 -12,3 -43.15% | -19,3 -17,6 -9.93% | -5,78 -13,5 57.18% | -9,95 -12,1 17.8% | -23,1 | -24,1 | -21,1 | |
|
EPS USD | Released Forecast Spread | -0,08 -0,02 -412.16% | -0,18 -0,06 -190.98% | -0,01 -0,05 79.8% | 0,00 0,00 - | -0,04 -0,03 -27.31% | -0,04 -0,04 -14.29% | -0,05 -0,05 -11.11% | -0,01 -0,03 67.86% | -0,02 -0,03 37.5% | -0,05 | -0,05 | -0,05 | -0,01 |
| Announcement Date | 04/05/22 | 03/08/22 | 27/10/22 | 01/03/23 | 03/05/23 | 02/08/23 | 01/11/23 | 29/02/24 | 01/05/24 | - | - | - | - |
More events
Past sector events for Amarin Corporation plc
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AMRN Stock
- Calendar Amarin Corporation plc
